Prodromal Marker Progression in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Sample Size for Clinical Trials

To estimate prodromal marker progression in idiopathic rapid eye movement sleep behavior disorder patients with prodromal Parkinson's disease (PD) to calculate sample size for neuroprotective trials.

[1]  C. Cupidi,et al.  The largest caucasian kindred with dentatorubral‐pallidoluysian atrophy: A founder mutation in italy , 2019, Movement disorders : official journal of the Movement Disorder Society.

[2]  S. Fereshtehnejad,et al.  Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. , 2019, Brain : a journal of neurology.

[3]  Yves Dauvilliers,et al.  Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study , 2019, Brain : a journal of neurology.

[4]  Anirvan Ghosh,et al.  Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial , 2018, Movement disorders : official journal of the Movement Disorder Society.

[5]  R. Postuma,et al.  How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder , 2017, Annals of neurology.

[6]  E. Tolosa,et al.  Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder , 2017, Annals of neurology.

[7]  D. Jennings,et al.  Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort , 2017, JAMA neurology.

[8]  S. Fereshtehnejad,et al.  Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort , 2017, Movement disorders : official journal of the Movement Disorder Society.

[9]  Jane S. Paulsen,et al.  HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD) , 2016, Quality of Life Research.

[10]  Norbert Kovács,et al.  Minimal clinically important difference on the Motor Examination part of MDS-UPDRS. , 2015, Parkinsonism & related disorders.

[11]  Günther Deuschl,et al.  MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[12]  R. Postuma,et al.  Parkinson risk in idiopathic REM sleep behavior disorder , 2015, Neurology.

[13]  J. Molinuevo,et al.  Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study , 2011, The Lancet Neurology.

[14]  R. Hauser,et al.  Determination of minimal clinically important change in early and advanced Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[15]  R. Postuma,et al.  Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. , 2009, Brain : a journal of neurology.

[16]  J. Bergquist,et al.  Irreversible motor impairment in young addicts – ephedrone, manganism or both? , 2007, Acta neurologica Scandinavica.

[17]  Steven P. Reise,et al.  The role of the bifactor model in resolving dimensionality issues in health outcomes measures , 2007, Quality of Life Research.

[18]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[19]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[20]  Bonnet Am.  [The Unified Parkinson's Disease Rating Scale]. , 2000 .

[21]  E. Siemers,et al.  Rate of functional decline in Huntington’s disease , 2000, Neurology.

[22]  R. Doty,et al.  Development of the 12‐Item Cross‐Cultural Smell Identification Test(CC‐SIT) , 1996, The Laryngoscope.

[23]  D. Greenblatt,et al.  The International Classification of Sleep Disorders , 1992 .

[24]  B. Everitt.  Multivariate Analysis: The Need for Data, and other Problems , 1975, British Journal of Psychiatry.

[25]  Dean Farnsworth,et al.  The Farnsworth-Munsell 100-Hue and Dichotomous Tests for Color Vision* , 1943 .